Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Patents and intellectual property

Technology managers should include the following elements in the plan itself the critical business issues the nature of markets and customers the thmsts of traditional and potential competitors the human resource issues, ie, the skills and abiUties needed to carry out the plan alternatives and contingencies to support the plan a patent and intellectual property strategy and the supporting faciUties and resource plan. The most frequentiy overlooked elements are human resource issues and patent strategies (50). [Pg.131]

The benefits of nasally delivered products are their rapid onset of action under avoidance of gastrointestinal breakdown and first-pass metabolism. Furthermore, nasal drugs can be administered at a lower dose, which also means fewer side effects. Other benefits include economical reasons, such as the extensions of patents and intellectual property rights, the economic efficiency of fhe healfhcare systems, and of course, patient compliance. [Pg.1207]

Patent and intellectual property aspects—Patent protection in Switzerland lasts for 20 years, with the possibility of a 5-year extension with a supplementary protection certificate (SPC). Also of interest is that the initial applicant has 10-year exclusivity protection for new active substances, new routes of administration and/or new dosage forms. [Pg.685]

Waller FJ (2011) Writing chemistry patents and intellectual property. A practical guide, Wiley, Hoboken... [Pg.341]

The requirements for regulatory approval and intellectual property management, and in particular the ability to file USPTO patent submissions, do place constraints on what systems can be applied for record keeping, but the good news is that there are no insurmountable barriers to these records being captured and managed electronically. [Pg.211]

Vol. 587 P. N. Baecker, Real Options and Intellectual Property Capital Budgeting Under Imperfect Patent Protection. X, 276 pages, 2007. [Pg.245]

See C. MacLeod, Concepts of Invention and the Patent Controversy in Britain] in R. Fox (ed.), Technological Change. Methods and Themes in the History of Technology (Amsterdam Harwood Academic Publishers, 1996), pp. 137-53 C. MacLeod, James Watt, Heroic Invention and the Idea of the Industrial Revolution] in M. Berg and K. Bruland (eds), Technological Revolutions in Europe. Historical Perspectives (Cheltenham Edward Elgar, 1998), pp. 96-116 MacLeod, Heroes of Invention, pp. 249-79, 304. See also C. Pettitt, Patent Inventions. Intellectual Property and the Victorian Novel (New York Oxford University Press, 2004). [Pg.195]

A repository of general interest in patent literature and intellectual property-related news and decisions, is available through IP News Flash at http //www.ipnewsflash.com. It is updated hourly with up-to-date information on patents and other inteUecmal property-related matters. The site offers an e-mail news feed with content dehvered daily or monthly, as well. [Pg.270]

With the intense competition and the turmoil in the United States due to downsizing and restructuring of companies, intellectual property may walk out the door. What a company knows has become as important as what it produces [6]. Intangible and invisible assets such as knowledge, competence of employees, information systems, and intellectual property (e.g., patent details, trade secrets, customer lists) do not show up on the bottom line but are as valuable as... [Pg.377]

According to the PHS Policy Statement on CRADAs and intellectual property licensing, In certain areas of research, e.g., where the Government has the intellectual lead or where both scientific and commercialization capabilities are deemed essential at the outset, NIH/ADAMHA may competitively seek a collaborator through Federal Register notification. The Patent Policy Board has left to each institute the decision of when to publish in the Federal Register (486). [Pg.224]

Caulfield T (2004). Biotechnology Patents, Public Trust and Patent Pools The Need for Governance Health Biotechnology and Intellectual Property A New Framework. Hosted at the European University Institute, Florence, Italy. [Pg.1427]


See other pages where Patents and intellectual property is mentioned: [Pg.232]    [Pg.253]    [Pg.350]    [Pg.534]    [Pg.50]    [Pg.371]    [Pg.710]    [Pg.1833]    [Pg.1835]    [Pg.1837]    [Pg.1839]    [Pg.1913]    [Pg.1930]    [Pg.942]    [Pg.269]    [Pg.164]    [Pg.366]    [Pg.132]    [Pg.232]    [Pg.253]    [Pg.350]    [Pg.534]    [Pg.50]    [Pg.371]    [Pg.710]    [Pg.1833]    [Pg.1835]    [Pg.1837]    [Pg.1839]    [Pg.1913]    [Pg.1930]    [Pg.942]    [Pg.269]    [Pg.164]    [Pg.366]    [Pg.132]    [Pg.450]    [Pg.603]    [Pg.37]    [Pg.169]    [Pg.247]    [Pg.211]    [Pg.298]    [Pg.301]    [Pg.91]    [Pg.116]    [Pg.212]    [Pg.681]    [Pg.44]    [Pg.344]    [Pg.475]    [Pg.277]    [Pg.475]    [Pg.1430]    [Pg.495]   
See also in sourсe #XX -- [ Pg.1831 , Pg.1832 , Pg.1833 , Pg.1834 , Pg.1835 , Pg.1836 , Pg.1837 , Pg.1838 ]

See also in sourсe #XX -- [ Pg.73 ]




SEARCH



And intellectuals

Intellectual property

Intellectual property patents

Patents property)

© 2024 chempedia.info